Exact Sciences Corp. (EXAS) said that it expects revenue to be between $464.5 million and $467.5 million for the fourth quarter ended December 31, 2020. Analysts polled by Thomson Reuters expect the company to report revenues of $431.18 million for the fourth-quarter. Analysts' estimates typically exclude special items.
The company expects fourth-quarter Screening revenue to be in the range of $249 million - $250 million, an increase of 9 percent from last year. It projects COVID-19 testing revenue between $98.5 million and $99.5 million for the fourth-quarter.
For the twelve-month period ended December 31, 2020, the company projects total revenue to be between $1.490 billion and $1.493 billion, COVID-19 testing revenue of $235 million - $236 million.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.